Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ABVCthis companyABVC BioPharma, Inc.	$0.98	-5.46×	4.46×	0×	-7.04×	-109.1%	0.0%	0.0%	0.0%	-71.2%	-42.6%	-6.0%	0.31×	-0.38×	-17.2×	0.41×	0.0%	1	-5.28	1	C-
ATNMActinium Pharmaceuticals, Inc.	$1.43	-1.25×	5.42×	471.4×	0.12×	0.8%	100.0%	-40274.4%	-37652.2%	-432.6%	-81.4%	-58.2%	0.22×	1.4×	0×	6.2×	0.0%	4	-8.02	5	S-
GRCEGrace Therapeutics, Inc.	$1.91	-9.85×	1.2×	0×	-5.37×	-60.9%	0.0%	0.0%	0.0%	-12.2%	-14.1%	-11.6%	0×	1.53×	0×	8.1×	0.0%	2	5.07	2	C+
JUNSJupiter Neurosciences, Inc.	$2.16	-4.08×	-19.28×	1,620.54×	-4.3×	-239.6%	80.6%	-40873.2%	-39662.8%	471.9%	-255.4%	-15.3%	-2.9×	-0.18×	-134.94×	0.65×	0.0%	3	-23.07	2	C
LTRNLantern Pharma Inc.	$0.57	-1.93×	5.05×	0×	-6.26×	-1222.3%	0.0%	0.0%	0.0%	-262.0%	-21.1%	-47.5%	12.02×	-4.33×	0×	2.4×	0.0%	1	-22.94	2	C+
PDSBPDS Biotechnology Corporation	$1.15	-1.04×	3.86×	0×	-0.86×	-89.5%	0.0%	0.0%	0.0%	-372.9%	-116.5%	-77.7%	1.83×	0.32×	-5.91×	2.98×	0.0%	2	-44.34	2	C
Peer median	—	-1.93×	3.86×	0×	-4.3×	-89.5%	0.0%	0.0%	0.0%	-262.0%	-81.4%	-47.5%	0.22×	0.32×	0×	2.98×	0.0%	2	-22.94	2	—